120 related articles for article (PubMed ID: 38364458)
1. Circulating TNF-RII, IP-10 and HGF are associated with severity of COVID-19 in oncologic patients.
Carrillo-García J; Lacerenza S; Hindi N; Moura DS; Marquina G; Parra Corral D; Olalla J; María Cano Cano J; Hoyos S; Renshaw M; Mondaza-Hernández JL; Di Lernia D; Casado A; Manzano A; Gutierrez A; Martin-Broto J
Cytokine; 2024 May; 177():156542. PubMed ID: 38364458
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Quartuccio L; Fabris M; Sonaglia A; Peghin M; Domenis R; Cifù A; Curcio F; Tascini C
Cytokine; 2021 Apr; 140():155438. PubMed ID: 33493861
[TBL] [Abstract][Full Text] [Related]
3. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19.
Acevedo N; Escamilla-Gil JM; Espinoza H; Regino R; Ramírez J; Florez de Arco L; Dennis R; Torres-Duque CA; Caraballo L
Front Immunol; 2021; 12():678661. PubMed ID: 34335580
[TBL] [Abstract][Full Text] [Related]
5. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
6. Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19.
Yang Y; Shen C; Li J; Yuan J; Wei J; Huang F; Wang F; Li G; Li Y; Xing L; Peng L; Yang M; Cao M; Zheng H; Wu W; Zou R; Li D; Xu Z; Wang H; Zhang M; Zhang Z; Gao GF; Jiang C; Liu L; Liu Y
J Allergy Clin Immunol; 2020 Jul; 146(1):119-127.e4. PubMed ID: 32360286
[TBL] [Abstract][Full Text] [Related]
7. Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
Peart Akindele N; Kouo T; Karaba AH; Gordon O; Fenstermacher KZJ; Beaudry J; Rubens JH; Atik CC; Zhou W; Ji H; Tao X; Vaidya D; Mostafa H; Caturegli P; Blair PW; Sauer L; Cox AL; Persaud D
J Infect Dis; 2021 Aug; 224(4):606-615. PubMed ID: 34398245
[TBL] [Abstract][Full Text] [Related]
8. TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a prospective cohort study.
Tegethoff SA; Danziger G; Kühn D; Kimmer C; Adams T; Heintz L; Metz C; Reifenrath K; Angresius R; Mang S; Rixecker T; Becker A; Geisel J; Jentgen C; Seiler F; Reichert MC; Fröhlich F; Meyer S; Rissland J; Ewen S; Wagenpfeil G; Last K; Smola S; Bals R; Lammert F; Becker SL; Krawczyk M; Lepper PM; Papan C
Int J Infect Dis; 2022 Sep; 122():178-187. PubMed ID: 35643306
[TBL] [Abstract][Full Text] [Related]
9. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
10. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19.
Chen Y; Wang J; Liu C; Su L; Zhang D; Fan J; Yang Y; Xiao M; Xie J; Xu Y; Li Y; Zhang S
Mol Med; 2020 Oct; 26(1):97. PubMed ID: 33121429
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
[TBL] [Abstract][Full Text] [Related]
12. Serum IP-10 and IL-7 levels are associated with disease severity of coronavirus disease 2019.
Wang GL; Gao HX; Wang YL; Wei X; Liu YZ; Lu JH; Li L; Wang HB; Zhao L; Rong YX; Yao L; Duan LJ; Anderson BD; Ma MJ; Dai EH; Zhao XN
Cytokine; 2021 Jun; 142():155500. PubMed ID: 33810947
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
mBio; 2021 May; 12(3):. PubMed ID: 33947753
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
[TBL] [Abstract][Full Text] [Related]
15. [The possible mechanism of lung injury induced by severe acute respiratory syndrome coronavirus spike glycoprotein].
Yang XY; Yao GH; Xu J; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):587-90. PubMed ID: 17129463
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.
Glossop JR; Dawes PT; Nixon NB; Mattey DL
Arthritis Res Ther; 2005; 7(6):R1227-34. PubMed ID: 16277675
[TBL] [Abstract][Full Text] [Related]
17. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses.
Kwon JS; Kim JY; Kim MC; Park SY; Kim BN; Bae S; Cha HH; Jung J; Kim MJ; Lee MJ; Choi SH; Chung JW; Shin EC; Kim SH
Am J Trop Med Hyg; 2020 Dec; 103(6):2412-2418. PubMed ID: 33124544
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
20. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
